First characterization of Plasmodium vivax liver stage antigen (PvLSA) using synthetic peptides

Parasites and Vectors

Volumn 7, Issue 1, 2014, Pages

  Goo, Youn Kyoung ^a,b   Seo, Eun Jeong ^a   Choi, Yeon Kyung ^a   Shin, Hyun Il ^a   Sattabongkot, Jetsumon ^c   Ji, So Young ^a   Chong, Chom Kyu ^d   Cho, Shin Hyung ^a   Lee, Won Ja ^a   Kim, Jung Yeon ^a  

^a Korea National Institute of Health   (South Korea)

^b Kyungpook National University School of Medicine   (South Korea)

^c ARMED FORCES RESEARCH INSTITUTE OF MEDICAL SCIENCES   (Thailand)

^d Dankook University   (South Korea)

Author keywords

Liver stage antigen; Peptides; Plasmodium vivax

Indexed keywords

AMINO ACID SEQUENCE; ANTIBODIES, PROTOZOAN; ANTIGENS, PROTOZOAN; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; MALARIA, VIVAX; MOLECULAR SEQUENCE DATA; PEPTIDES; PLASMODIUM VIVAX;

EID: 84894475455     PISSN: None     EISSN: 17563305     Source Type: Journal    
DOI: 10.1186/1756-3305-7-64     Document Type: Article

References (24)

1. The global distribution and population at risk of malaria: past, present, and future. Hay SI, Guerra CA, Tatem AJ, Noor AM, Snow RW, Lancet Infect Dis 2004 4 327 336 (Pubitemid 38692697)
2. Vivax malaria: neglected and not benign. Price RN, Tjitra E, Guerra CA, Yeung S, White NJ, Anstey NM, Am J Trop Med Hyg 2007 77 79 87
3. Severe Plasmodium vivax malaria among Sudanese children at New Halfa Hospital, Eastern Sudan. Mahgoub H, Gasim GI, Musa IR, Adam I, Parasit Vectors 2012 5 154
4. Activation of the hypnozoite: a part of Plasmodium vivax life cycle and survival. Hulden L, Hulden L, Malar J 2011 10 90
5. Observation on hypnozoite of different isolates of Plasmodium vivax in cultured materials. Shu H, Lou S, Liu D, Fu R, Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi 1995 13 185 188
6. Molecular and epidemiological characterization of Plasmodium vivax recurrent infections in southern Mexico. Gonzalez-Ceron L, Mu J, Santillán F, Joy D, Sandoval MA, Camas G, Su X, Choy EV, Torreblanca R, Parasit Vectors 2013 6 109
7. First results of phase 3 trial of RTS, S/AS01 malaria vaccine in African children. Agnandji ST, Lell B, Soulanoudjingar SS, Fernandes JF, Abossolo BP, Conzelmann C, Methogo BG, Doucka Y, Flamen A, Mordmuller B, Issifou S, Kremsner PG, Sacarlal J, Aide P, Lanaspa M, Aponte JJ, Nhamuave A, Quelhas D, Bassat Q, Mandjate S, Macete E, Alonso P, Abdulla S, Salim N, Juma O, Shomari M, Shubis K, Machera F, Hamad AS, Minja R, et al. N Engl J Med 2011 365 1863 1875
8. Protection against Plasmodium falciparum malaria in chimpanzees by immunization with the conserved pre-erythrocytic liver-stage antigen 3. Daubersies P, Thomas AW, Millet P, Brahimi K, Langermans JA, Ollomo B, BenMohamed L, Slierendregt B, Eling W, Van Belkum A, Dubreuil G, Meis JF, Guerin-Marchand C, Cayphas S, Cohen J, Gras-Masse H, Druilhe P, Nat Med 2000 6 1258 1263
9. Long synthetic peptides encompassing the Plasmodium falciparum LSA3 are the target of human B and T cells and are potent inducers of B helper, T helper and cytolytic T cell responses in mice. Perlaza BL, Sauzet JP, Balde AT, Brahimi K, Tall A, Corradin G, Druilhe P, Eur J Immunol 2001 31 2200 2209 (Pubitemid 32640737)
10. Evidence for multiple B- and T-cell epitopes in Plasmodium falciparum liver-stage antigen 3. Toure-Balde A, Perlaza BL, Sauzet JP, Ndiaye M, Aribot G, Tall A, Sokhna C, Rogier C, Corradin G, Roussilhon C, Druilhe P, Infect Immun 2009 77 1189 1196
11. Usefulness of the recombinant liver stage antigen-3 for an early serodiagnosis of Plasmodium falciparum infection. Lee HW, Moon SU, Ryu HS, Kim YJ, Cho SH, Chung GT, Lin K, Na BK, Kong Y, Chung KS, Kim TS, Korean J Parasitol 2006 44 49 54
12. The liver in malaria with special reference to the exoerythrocytic phase. Garnham PC, Ann Trop Med Parasitol 1987 81 531 537 (Pubitemid 18077348)
13. Evaluation of two long synthetic merozoite surface protein 2 peptides as malaria vaccine candidates. Flueck C, Frank G, Smith T, Jafarshad A, Nebie I, Sirima SB, Olugbile S, Alonso P, Tanner M, Druilhe P, Felger I, Corradin G, Vaccine 2009 27 2653 2661
14. Longitudinal analyses of immune responses to Plasmodium falciparum derived peptides corresponding to novel blood stage antigens in coastal Kenya. Agak GW, Bejon P, Fegan G, Gicheru N, Villard V, Kajava AV, Marsh K, Corradin G, Vaccine 2008 26 1963 1971
15. Immunological profile of a Plasmodium vivax AMA-1 N-terminus peptide-carbon nanotube conjugate in an infected Plasmodium berghei mouse model. Yandar N, Pastorin G, Prato M, Bianco A, Patarroyo ME, Manuel Lozano J, Vaccine 2008 26 5864 5873
16. Synthetic polypeptides corresponding to the non-repeat regions from the circumsporozoite protein of Plasmodium falciparum: recognition by human T-cells and immunogenicity in owl monkeys. Lopez JA, Gonzalez JM, Kettner A, Arevalo-Herrera M, Herrera S, Corradin G, Roggero MA, Ann Trop Med Parasitol 1997 91 253 265 (Pubitemid 27214217)
17. On the pathogenesis of Plasmodium vivax malaria: perspectives from the Brazilian field. Costa FT, Lopes SC, Albrecht L, Ataide R, Siqueira AM, Souza RM, Russell B, Renia L, Marinho CR, Lacerda MV, Int J Parasitol 2012 42 1099 1105
18. An integrative approach to CTL epitope prediction: a combined algorithm integrating MHC class I binding, TAP transport efficiency, and proteasomal cleavage predictions. Larsen MV, Lundegaard C, Lamberth K, Buus S, Brunak S, Lund O, Nielsen M, Eur J Immunol 2005 35 2295 2303 (Pubitemid 41179750)
19. Predicting linear B-cell epitopes using string kernels. El-Manzalawy Y, Dobbs D, Honavar V, J Mol Recognit 2008 21 243 255 (Pubitemid 352019054)
20. Comparison of artificial membrane feeding with direct skin feeding to estimate the infectiousness of Plasmodium vivax gametocyte carriers to mosquitoes. Sattabongkot J, Maneechai N, Phunkitchar V, Eikarat N, Khuntirat B, Sirichaisinthop J, Burge R, Coleman RE, Am J Trop Med Hyg 2003 69 529 535 (Pubitemid 38248255)
21. Establishment of a human hepatocyte line that supports in vitro development of the exo-erythrocytic stages of the malaria parasites Plasmodium falciparum and P. vivax. Sattabongkot J, Yimamnuaychoke N, Leelaudomlipi S, Rasameesoraj M, Jenwithisuk R, Coleman RE, Udomsangpetch R, Cui L, Brewer TG, Am J Trop Med Hyg 2006 74 708 715 (Pubitemid 46774383)
22. Expression of truncated Babesia gibsoni thrombospondin-related adhesive proteins in Escherichia coli and evaluation of their diagnostic potential by enzyme-linked immunosorbent assay. Narantsatsral S, Goo YK, Battsetseg B, Myagmarsuren P, Terkawi MA, Soma T, Luo Y, Li Y, Cao S, Yu L, Kamyingkird K, Aboge GO, Nishikawa Y, Xuan X, Exp Parasitol 2011 129 196 202
23. Evaluation of circumsporozoite protein of Plasmodium vivax to estimate its prevalence in the Republic of Korea: an observational study of incidence. Cho PY, Lee SW, Ahn SK, Kim JS, Cha SH, Na BK, Park YK, Lee SK, Lee WJ, Nam HW, Hong SJ, Pak JH, Kang YJ, Sohn YJ, Bahk YY, Cho HI, Kim TS, Lee HW, Malar J 2013 12 448
24. Vaccination with M2e-based multiple antigenic peptides: characterization of the B cell response and protection efficacy in inbred and outbred mice. Wolf AI, Mozdzanowska K, Williams KL, Singer D, Richter M, Hoffmann R, Caton AJ, Otvos L, Erikson J, PLoS One 2011 6 28445